Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The O-antigen of lipopolysaccharide (LPS) on Vibrio cholerae O1 and O139 is a major surface carbohydrate structure that forms the outermost part of the LPS molecule on these bacteria[1][7]. It is essential for defining the serogroup (O1 or O139), acts as a principal determinant for immune system recognition, and serves as a key virulence factor. The O-antigen consists of repeating sugar units known as O-specific polysaccharide (OSP), with the O1 serogroup O-antigen composed of repeating units of perosamine, whereas the O139 O-antigen contains a unique non-repeating hexasaccharide distinct from O1[5]. This structural difference explains why immune responses or vaccines against one serogroup do not confer protection against the other[5][9]. The O-antigen participates in bacterial evasion of host immune defenses, modulates resistance to antimicrobial peptides, serves as a receptor for bacteriophages, and is a central target for vaccine development and immune-based diagnosis[1][7][9]. Vaccines targeting the O-antigen induce protective antibodies and reduce host colonization by V. cholerae. Changes or mutations affecting O-antigen biosynthesis can attenuate virulence and compromise bacterial survival[1][10].
Induction of O-antigen-specific antibodies (opsonization or inhibition of colonization); Target for vaccine-induced immune response (prevention of V. cholerae infection); Blocking O-antigen to neutralize pathogen or interfere with virulence
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on O-antigen of lipopolysaccharide of Vibrio cholerae O1 or O139.